lovastatin has been researched along with Cerebral Malaria in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canavese, M; Crisanti, A | 1 |
Assis, EF; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; d'Avila, JC; da Silva, TI; Estato, V; Reis, PA; Siqueira, LD; Tibiriça, EV; Zimmerman, GA | 1 |
2 other study(ies) available for lovastatin and Cerebral Malaria
Article | Year |
---|---|
Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
Topics: Animals; Antimalarials; Cytokines; Disease Models, Animal; Drug Synergism; Female; Heme Oxygenase-1; Inflammation; Lovastatin; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxidative Stress; Plasmodium berghei; Vascular Endothelial Growth Factor A | 2015 |
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
Topics: Animals; Brain; CD11b Antigen; Chemokines; Chloroquine; Cognition Disorders; Cytokines; Edema; Endothelium; Heme Oxygenase-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Leukocytes; Lovastatin; Malaria, Cerebral; Membrane Proteins; Mice; Mice, Inbred C57BL; Oxidative Stress; Plasmodium berghei; RNA, Messenger | 2012 |